VitalFlo

VitalFlo

Early Stage

VitalFlo helps doctors measure, monitor, and predict their patients' lung health

VitalFlo helps doctors measure, monitor, and predict their patients' lung health

Overview

Raised to Date: Raised: $261,828

Total Commitments ($USD)

Platform

Wefunder

Start Date

10/31/2022

Close Date

04/29/2023

Min. Goal
$185,000
Max. Goal
$1,000,000
Min. Investment

$250

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$7,000,000

Discount

20%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/30/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,455

# of Investors

127

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Location

Raleigh, North Carolina

Business Type

Growth

VitalFlo, with a valuation of $7 million, is raising funds on Wefunder. The company has developed a device and software that help doctors measure, monitor, and predict patients’ lung health. The VitalFlo device unlocks spirometry or pulmonary function testing for patients and their primary care doctors. The business launched with a 90-hospital Health System group in May 2022 and has reported a 2.7 times subscription growth quarter-over-quarter. Luke Marshall and Andy Taylor founded VitalFlo in April 2017. The current crowdfunding campaign has a minimum target of $275,000 and a maximum target of $1 million. The campaign proceeds will be used for R&D, sales and marketing, and general and administrative expenses.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$72,690

$42,877

COGS

$43,118

$1,937

Tax

$200

$204

 

 

Net Income

$-741,679

$-159,223

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$712,911

$141,748

Accounts Receivable

$16,543

$11,619

Total Assets

$877,926

$267,729

Short-Term Debt

$39,277

$75,823

Long-Term Debt

$0

$725,000

Total Liabilities

$39,277

$800,823

Financials as of: 10/31/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

One in 13 Americans suffer from asthma. And asthma is just one of the many reasons someone might have to undergo lung function testing. These tests typically involve a device called a peak flow meter (aka spirometer), which measures the airflow that comes out of the lungs. It is the most common way to track lung function for those with asthma, allergies, chronic obstructive pulmonary disease, and other conditions that affect breathing. Normally, the test has to be done in a doctor’s office, usually a specialist’s. And because of patient backlogs, waiting weeks or months to have a test done is not unusual. 

VitalFlo was founded to make lung function testing as easy as taking your blood pressure. Founder and CEO Luke Marshall saw how much inconvenience and wasted time patients were going through. That’s why he and the VitalFlo team built out software to make lung function testing available at home or in primary care offices.

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
VitalFlo on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $7,000,000

Follow company

Follow VitalFlo on Wefunder 2022

Buy VitalFlo's Deal Report

Warning: according to the close date for this deal, VitalFlo may no longer be accepting investments.

VitalFlo Deal Report

Get KingsCrowd’s comprehensive report on VitalFlo including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether VitalFlo is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the VitalFlo deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge